Condition
AIDS-Related Diffuse Large B-cell Lymphoma
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
3 shownImmune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin LymphomaNCT05077527 · 2025-02-13
RECRUITINGAMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")NCT07649304 · 2026-10-09
NOT_YET_RECRUITINGGene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin LymphomaNCT02337985 · 2015-11-20
ACTIVE_NOT_RECRUITINGCommon interventions
CyclophosphamideDRUG3Doxorubicin HydrochlorideDRUG2PrednisoneDRUG2RituximabBIOLOGICAL2Vincristine SulfateDRUG2Axicabtagene CiloleucelBIOLOGICAL1Biopsy ProcedurePROCEDURE1Biospecimen CollectionPROCEDURE1Bone Marrow AspirationPROCEDURE1Bone Marrow BiopsyPROCEDURE1Computed TomographyPROCEDURE1Echocardiography TestPROCEDURE1EtoposideDRUG1FilgrastimBIOLOGICAL1FludarabineDRUG1GlofitamabBIOLOGICAL1Lentivirus Vector rHIV7-shI-TAR-CCR5RZ-transduced Hematopoietic Stem/Progenitor CellsBIOLOGICAL1Positron Emission TomographyPROCEDURE1Questionnaire AdministrationOTHER1
Leading sponsors
Trial status mix
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
RECRUITING1
Phase mix
PHASE13
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.